BioXcel Therapeutics, Inc. (BTAI) › RevenueBioXcel Therapeutics, Inc. (BTAI) — RevenueAnnual figures by period end, from SEC filings.2022-12-31: $375.0K2023-12-31: $1.38M2024-12-31: $2.27M2025-12-31: $642.0K$642.0K2022-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$642.0K-71.7%2026-03-27From 2025-01-012024-12-31$2.27M+64.2%2026-03-27From 2024-01-012023-12-31$1.38M+268.0%2025-03-28From 2023-01-012022-12-31$375.0K—2024-03-22From 2022-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)